S
Sonoma Pharmaceuticals, Inc. (SNOA)
NCM – Real Time Price. Currency in USD
1.12
-0.02 (-1.75%)
At close: Jun 26, 2026, 4:00 PM EDT
1.12
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.12
-0.02 (-1.75%)
At close: Jun 26, 2026, 4:00 PM EDT
1.12
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $2.4M significantly exceed its total debt $842.0K, ensuring strong financial flexibility
Total current assets $12.0M exceed Total current liabilities $4.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.3) is well below the industry average (-0.8), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$548.0K limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.49 | 2.52 | 10 | |
| Quick ratio | 1.73 | 1.78 | 8.0 | |
| Debt to Equity | 0.27 | -0.80 | 8.0 | |
| Debt to Assets | 0.06 | 0.73 | 9.0 | |
| Interest coverage | N/A | -13.90 | 1.0 | |
| Weighted average score | 7.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 13M | 13M | 14M | 20M | 20M |
| Gross Profit | 4M | 5M | 5M | 7M | 7M |
| Operating Income | -5M | -5M | -4M | -2M | -2M |
| Net Income | -5M | -5M | -3M | -3M | -3M |
| EBITDA | -4M | -5M | -4M | -2M | -2M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 24.28 | 60.53 | 10 |
| Next quarter | -5.6 | 68.75 | 5.5 |
| Current year | 22.44 | 70.37 | 10 |
| Next year | 12.73 | 112.5 | 9.0 |
| Weighted average score | 8.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 27.87 | 29.06 | 31.25 | 32.43 | 10 |
| Y/Y | 48.14 | 25.13 | -117.07 | -285.91 | 5.5 |
| 3y average | 14.94 | 14.26 | 50.51 | -733.3 | 6.8 |
| 5y average | 3.55 | 6.76 | 50.51 | -453.91 | 5.0 |
| Weighted average score | 6.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |